Group One Trading’s Denali Therapeutics DNLI Stock Holding History

Group One Trading’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,691	Closed	-$43.3K	–	7414
2024 Q3	$49.3K	Buy	+1,691	New	+$41.9K	﹤0.01%	4660
2024 Q2	–	Sell	-8,455	Closed	-$162K	–	6878
2024 Q1	$173K	Buy	+8,455	New	+$159K	﹤0.01%	3688
2023 Q2	–	Sell	-49,760	Closed	-$1.4M	–	7752
2023 Q1	$1.15M	Buy	+49,760	New	+$1.37M	﹤0.01%	2019
2022 Q3	–	Sell	-3,522	Closed	-$115K	–	7661
2022 Q2	$104K	Sell	3,522 -3,437	-49%	-$90K	﹤0.01%	4948
2022 Q1	$224K	Sell	6,959 -7,386	-51%	-$254K	﹤0.01%	4683
2021 Q4	$640K	Buy	+14,345	New	+$680K	﹤0.01%	3842
2021 Q3	–	Sell	-1,193	Closed	-$67.2K	–	8284
2021 Q2	$94K	Buy	+1,193	New	+$73.8K	﹤0.01%	6025
2020 Q2	–	Sell	-5,756	Closed	-$135K	–	5855
2020 Q1	$101K	Buy	+5,756	New	+$120K	﹤0.01%	3287
2019 Q4	–	Sell	-2,200	Closed	-$36.6K	–	5197
2019 Q3	$34K	Buy	+2,200	New	+$42K	﹤0.01%	4159
2019 Q1	–	Sell	-100	Closed	-$2.09K	–	4918
2018 Q4	$2K	Buy	+100	New	+$1.81K	﹤0.01%	4649

Other funds holding DNLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's DNLI Position: Q4 2024 in Review

Group One Trading sold out of Denali Therapeutics (DNLI) in Q4 2024, closing a stake of 1,691 shares — an estimated $43.3K sold.

Group One Trading first reported a position in DNLI in Q4 2018 and held it in 10 quarters. The position peaked at $1.15M in Q1 2023. 223 funds tracked by Wall St. Rank hold DNLI as of Q4 2024.

Group One Trading reported no remaining Denali Therapeutics position as of Q4 2024 after selling out during the quarter.
Group One Trading sold 1,691 Denali Therapeutics shares in Q4 2024, an estimated $43.3K.
Group One Trading first reported a position in Denali Therapeutics in Q4 2018 and held it in 10 quarters.
Group One Trading's Denali Therapeutics position peaked at $1.15M in Q1 2023.
223 funds tracked by Wall St. Rank held Denali Therapeutics as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.